Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Launches Digital Modernization Plan To Complement Its Technology Modernization Plan

Executive Summary

Agency heads say the new plan will siphon and aggregate more data that could help the regulatory body make better and faster regulatory decisions.

You may also be interested in...



FDA Provides Update On Efforts To Modernize Its Technology And Data Collection

After launching its Data Modernization Action Plan (DMAP) one year ago, and its Technology Modernization Action Plan (TMAP) three years ago, the US Food and Drug Administration has provided an update to its progress with “Modernization in Action.”

Biden’s Budget Would Give $6.5Bn To FDA, Including $677M To Device Center

The funding plan from the US president, which is up 8% from fiscal 2021, prioritizes infrastructure, public health, and safety programs.

US FDA’s Abernethy Leaves Behind Legacy Of Tech Modernization, Real-World Data

After slightly more than two years as second-in-command, Abernethy says she’s leaving FDA because her initiatives were starting to develop their own momentum. Abernethy, who the agency’s acting chief information officer, worked to modernize FDA’s information technology infrastructure and data capabilities while also exploring confidently using real-world data to support regulatory decision-making.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT143602

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel